GeneDx Holdings (WGS) Gains from Investment Securities (2020 - 2026)

GeneDx Holdings (WGS) has reported Gains from Investment Securities for 7 consecutive years, with -$220000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gains from Investment Securities rose 89.91% year-over-year to -$220000.0 in Q2 2026; TTM through Jun 2026 was -$475000.0, a 126.7% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 90.99% from the prior year.
• Gains from Investment Securities was -$220000.0 for Q2 2026 at GeneDx Holdings, up from -$2.5 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $6.1 million in Q1 2024 and troughed at -$28.2 million in Q2 2022.
• A 5-year average of -$3.3 million and a median of -$538000.0 in 2023 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities surged 507.41% in 2024 and sank 330.91% in 2026, its largest moves.
• Over 5 years, Gains from Investment Securities stood at -$15.9 million in 2022, then surged by 96.94% to -$486000.0 in 2023, then surged by 507.41% to $2.0 million in 2024, then plunged by 156.36% to -$1.1 million in 2025, then soared by 80.29% to -$220000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$220000.0 (Q2 2026), -$2.5 million (Q1 2026), and -$1.1 million (Q4 2025), per Business Quant data.